For the Inventor, By the Inventor

Enter assignee name

Cambridge, United Kingdom

Proximagen Limited

USPTO Granted Patents = 38

CIPO Patents = 2

EPO Patents = 20

Trademarks = 2

Forward Citations = 75

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Edward Savory (22 out of 27 patents)

Iain Simpson (16 out of 25 patents)

Lee Patient (15 out of 17 patents)

4. David Evans (11 out of 16 patents)

5. Michael Higginbottom (10 out of 17 patents)

6. Max Espensen (9 out of 9 patents)

7. Kathryn Oliver (8 out of 10 patents)

8. Viet-Anh Anne Horgan (5 out of 9 patents)

9. Alison Stewart (5 out of 5 patents)

10. Allison Carley (5 out of 5 patents)

11. Andrew Lightfoot (4 out of 11 patents)

12. Kevin Dinnell (4 out of 15 patents)

13. Giles Brown (3 out of 3 patents)

14. Andrew Graham Cole (3 out of 11 patents)

15. Peter Richardson (2 out of 5 patents)

38 patents: Sort by Forward Citations

1. 11530208 - Imidazo[4,5-C]pyridine derived SSAO inhibitors (2022-12-20),

2. 11512082 - Substituted imidazo[4,5-c]pyridine compounds and compositions thereof (2022-11-29),

3. 11369616 - Drug combination and its use in therapy (2022-06-28),

4. 11311552 - Therapies for cancer (2022-04-26),

5. 10995091 - CXCR4 receptor antagonists (2021-05-04),

6. 10968223 - Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors (2021-04-06),

7. 10766897 - Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors (2020-09-08),

8. 10738044 - Therapeutic compound and use in therapy (2020-08-11),

9. 10590125 - Compounds (2020-03-17),

10. 10428066 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2019-10-01),

11. 10155761 - CXCR4 receptor antagonists (2018-12-18),

12. 10065954 - Substituted imidazo[4,5-c]pyridines as SSAO inhibitors (2018-09-04),

13. 9951068 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2018-04-24),

14. 9890160 - Compounds I (2018-02-13),

15. 9676769 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2017-06-13),

Proximagen Limited is a leading biotechnology company that specializes in the discovery and development of novel therapeutic products for CNS disorders. With a focus on neurological and psychiatric conditions, the company works on innovative research, drug discovery, and clinical development. Proximagen's passion for advancing CNS therapies drives their commitment to improving patient lives and addressing unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

38 Patents

#26 in Cambridge

#457 in United Kingdom

#17,312 in the World

Cambridge, United Kingdom

Proximagen Limited

Forward Citations = 75

50 inventors:

Edward Savory (22 out of 27 patents)

Iain Simpson (16 out of 25 patents)

Lee Patient (15 out of 17 patents)

4. David Evans (11 out of 16 patents)

5. Michael Higginbottom (10 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…